 Now, by 21, there was already a push to offer chemical abortion drugs through telemedicine. COVID accelerated that. And in December 21, the FDA made permanent what had started as a temporary exception, removing that last day one in-person dispensing requirement. The FDA continued to identify emergency medical care, not providers, as the backstop for complications.